Literature DB >> 28871566

Natural killer cells and tumor metastasis.

Hwan Hee Lee1,2, Hyojeung Kang3, Hyosun Cho4,5.   

Abstract

Natural killer (NK) cells are cytotoxic lymphocytes that recognize tumor cells or stressed cells through 'missing-self' signals, such as altered or absent expression of MHC class I molecules. The function of NK cells is regulated by the activation or inhibition of receptors present on their surface. The activation of NK cells results in cytotoxic activity on target cells through release of toxic granules and inflammatory cytokines. However, NK cells infiltrating tumors have been frequently shown to exhibit a skewed phenotype that includes decreased antitumor activity and enhanced protumor activities, such as angiogenesis and metastasis. In fact, many studies have reported that tumor microenvironments induce a protumor phenotype in NK cells. Here, we review the biological properties of NK cells in the context of tumorigenesis and tumor progression, with a specific focus on the interactions between NK cells and critical tumor microenvironments, such as epithelial-to-mesenchymal transition, matrix metalloproteinases, and tumor-associated chronic inflammation in tumor metastasis.

Entities:  

Keywords:  Chronic inflammation; EMT; MMPs; Natural killer cells; Tumor metastasis

Mesh:

Substances:

Year:  2017        PMID: 28871566     DOI: 10.1007/s12272-017-0951-9

Source DB:  PubMed          Journal:  Arch Pharm Res        ISSN: 0253-6269            Impact factor:   4.946


  8 in total

1.  Absolute Counts of Peripheral Lymphocyte Subsets Correlate with the Progression-Free Survival and Metastatic Status of Pancreatic Neuroendocrine Tumour Patients.

Authors:  Yitao Gong; Zhiyao Fan; Guopei Luo; Qiuyi Huang; Yunzhen Qian; He Cheng; Kaizhou Jin; Quanxing Ni; Xianjun Yu; Chen Liu
Journal:  Cancer Manag Res       Date:  2020-08-03       Impact factor: 3.989

2.  PNSA, a Novel C-Terminal Inhibitor of HSP90, Reverses Epithelial-Mesenchymal Transition and Suppresses Metastasis of Breast Cancer Cells In Vitro.

Authors:  Aotong Zhang; Xin Qi; Fu Du; Guojian Zhang; Dehai Li; Jing Li
Journal:  Mar Drugs       Date:  2021-02-20       Impact factor: 5.118

3.  Development of allogeneic HSC-engineered iNKT cells for off-the-shelf cancer immunotherapy.

Authors:  Yan-Ruide Li; Yang Zhou; Yu Jeong Kim; Yanni Zhu; Feiyang Ma; Jiaji Yu; Yu-Chen Wang; Xianhui Chen; Zhe Li; Samuel Zeng; Xi Wang; Derek Lee; Josh Ku; Tasha Tsao; Christian Hardoy; Jie Huang; Donghui Cheng; Amélie Montel-Hagen; Christopher S Seet; Gay M Crooks; Sarah M Larson; Joshua P Sasine; Xiaoyan Wang; Matteo Pellegrini; Antoni Ribas; Donald B Kohn; Owen Witte; Pin Wang; Lili Yang
Journal:  Cell Rep Med       Date:  2021-11-16

Review 4.  Immunological Insights into Opioid-Free Anaesthesia in Oncological Surgery: A Scoping Review.

Authors:  Laura Smith; Juan P Cata; Patrice Forget
Journal:  Curr Oncol Rep       Date:  2022-05-28       Impact factor: 5.945

Review 5.  Cancer drug resistance induced by EMT: novel therapeutic strategies.

Authors:  Javier De Las Rivas; Anamaria Brozovic; Sivan Izraely; Alba Casas-Pais; Isaac P Witz; Angélica Figueroa
Journal:  Arch Toxicol       Date:  2021-05-18       Impact factor: 5.153

6.  Lactic Acid Bacteria from Kefir Increase Cytotoxicity of Natural Killer Cells to Tumor Cells.

Authors:  Takuya Yamane; Tatsuji Sakamoto; Takenori Nakagaki; Yoshihisa Nakano
Journal:  Foods       Date:  2018-03-27

7.  Cytokine-Modulated Natural Killer Cells Differentially Regulate the Activity of the Hepatitis C Virus.

Authors:  Yoo Jin Cho; Hwan Hee Lee; Hyojeung Kang; Hyosun Cho
Journal:  Int J Mol Sci       Date:  2018-09-14       Impact factor: 5.923

Review 8.  Reversal of the immunosuppressive tumor microenvironment by nanoparticle-based activation of immune-associated cells.

Authors:  Fei-Long Qi; Mei-Fang Wang; Bo-Zhao Li; Ze-Fang Lu; Guang-Jun Nie; Su-Ping Li
Journal:  Acta Pharmacol Sin       Date:  2020-05-28       Impact factor: 6.150

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.